<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04842461</url>
  </required_header>
  <id_info>
    <org_study_id>MHS</org_study_id>
    <nct_id>NCT04842461</nct_id>
  </id_info>
  <brief_title>Mental Health, Addictions and Biomarkers in High Athletes Performance</brief_title>
  <official_title>Presence of Psychopathy and Antisocial Personality Disorder as Well as Genetic Biomarkers and the Inhibition-prepulse Endophenotype in Elite Athletes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cardenal Herrera University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Villarreal CF</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Cardenal Herrera University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sport is a privileged area to promote socialization and health values, such as companionship;&#xD;
      a healthy lifestyle; cooperation to achieve common goals, and justice, rejecting unjustified&#xD;
      advantages in competition. The concept of fair play is on which the development of those&#xD;
      values pivots. From a holistic perspective, it is possible to define fair play, not only as a&#xD;
      way to participate but also as a way of projecting people in life with values, assuming a set&#xD;
      of behaviors that enhance a healthy and respectful sporting experience with opponents, the&#xD;
      companions, the spectators, the referees and all the agents that take part in the sport&#xD;
      practice.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Sport is a privileged area to promote socialization and health values, such as companionship;&#xD;
      a healthy lifestyle; cooperation to achieve common goals, and justice, rejecting unjustified&#xD;
      advantages in competition. The concept of fair play is on which the development of those&#xD;
      values pivots. From a holistic perspective, it is possible to define fair play, not only as a&#xD;
      way to participate but also as a way of projecting people in life with values, assuming a set&#xD;
      of behaviors that enhance a healthy and respectful sporting experience with opponents, the&#xD;
      companions, the spectators, the referees and all the agents that take part in the sport&#xD;
      practice.&#xD;
&#xD;
      Since 2018, joint actions have been carried out with the Villarreal de Fútbol Club, within&#xD;
      the framework of the ENDAVANT agreement. Within these actions, it is proposed to develop&#xD;
      different lines of research on sport and health. Within these lines, one of special relevance&#xD;
      is that related to the risk of consumption of illicit substances and / or behavioral&#xD;
      addictions, in elite athletes, since they are subjected to intense training days and stress&#xD;
      situations derived from the demands of performance of professional competitive activity. On&#xD;
      the other hand, recently published behavioral studies show that athletes who practice&#xD;
      non-contact sports have a greater capacity to identify and assess emotions than athletes who&#xD;
      practice contact sports and than those who practice contact sports show higher levels of&#xD;
      physical aggression or verbal, and hostility or anger, than athletes who practice individual&#xD;
      and non-contact sports.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 15, 2020</start_date>
  <completion_date type="Anticipated">July 31, 2022</completion_date>
  <primary_completion_date type="Actual">March 10, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>Common drugs</measure>
    <time_frame>2 years</time_frame>
    <description>Describe the consumption of common drugs in elite athletes.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Identify other mental disorders</measure>
    <time_frame>2 years</time_frame>
    <description>Identify other mental disorders differents than addictions and psychopathy in elite athletes.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Explore the consumption of new psychoactive substances</measure>
    <time_frame>2 years</time_frame>
    <description>Explore the consumption of new psychoactive substances in elite athletes</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pathological gambling</measure>
    <time_frame>2 years</time_frame>
    <description>Describe the study of behavioral addictions and video game addiction in elite athletes.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mental disorders</measure>
    <time_frame>2 years</time_frame>
    <description>Describe the presence of psychopathy and antisocial personality disorder</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Genetic biomarkers</measure>
    <time_frame>2 years</time_frame>
    <description>Describe genetic biomarkers endophenotype in elite athletes.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Dopping</measure>
    <time_frame>2 years</time_frame>
    <description>Describe new dopping substances in elite atheletes.</description>
  </primary_outcome>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Mental Disorder</condition>
  <condition>Anxiety</condition>
  <condition>Depression</condition>
  <condition>Substance Abuse</condition>
  <condition>Pathological Gambling</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Elite football players from Spanish football league&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  active athletes in the elite soccer competition from the Villarreal CF, who agree to&#xD;
             be included in the study by signing an informed consent and who have a health profile&#xD;
             made by the club's Medical Service.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  athletes who are transferred to other clubs during the study period.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Adolfo Muñoz Macho, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Medical Services of Villarreal CF SAD</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Isabel Almodóvar Fernández, PhD</last_name>
    <phone>0034636760923</phone>
    <email>isabelalmodovarfernandez@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Isabel Almoodóvar Fernández, PhD</last_name>
    <phone>0034636760923</phone>
    <email>isabelalmodovarfernandez@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Villarreal CF</name>
      <address>
        <city>Villa-Real</city>
        <state>Castellón</state>
        <zip>12540</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Isabel Almodóvar Fernández, PhD</last_name>
      <phone>0034636760923</phone>
      <email>isabelalmodovarfernandez@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Antonio Real Fernández, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Adolfo Muñoz Macho, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hector Usó Vicent</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Isabel Aleixandre Górriz, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Paula Sáchez Thevenet, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gonzalo Rafael Haro Cortés, Phd MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Isabel Almodóvar Fernández, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alejandro Fuertes Saiz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lidia Ibañez Torres, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rafael González Moret, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Villarreal CF</name>
      <address>
        <city>Villarreal</city>
        <state>Castellón</state>
        <zip>12540</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Isabel Almodóvar Fernández, PhD</last_name>
      <phone>0034636760923</phone>
      <email>isabelalmodovarfernandez@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Adolfo Muñoz Macho, MD</last_name>
      <phone>0034619131738</phone>
      <email>dradolfomunoz@villarrealcf.es</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 7, 2021</study_first_submitted>
  <study_first_submitted_qc>April 9, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 13, 2021</study_first_posted>
  <last_update_submitted>April 9, 2021</last_update_submitted>
  <last_update_submitted_qc>April 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cardenal Herrera University</investigator_affiliation>
    <investigator_full_name>Isabel Almodóvar Fernández</investigator_full_name>
    <investigator_title>PhD</investigator_title>
  </responsible_party>
  <keyword>mental disorder</keyword>
  <keyword>gambling</keyword>
  <keyword>despression</keyword>
  <keyword>anxiety</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Substance-Related Disorders</mesh_term>
    <mesh_term>Mental Disorders</mesh_term>
    <mesh_term>Psychotic Disorders</mesh_term>
    <mesh_term>Gambling</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

